Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis

We treated patients with C-viral chronic hepatitis (CH) and liver cirrhosis (LC) with polaprezinc and determined prospectively the effect on long-term outcome. 62 patients were enrolled. Of these, 32 were administered 1.0 g polaprezinc and the remainder were not administered polaprezinc. We measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Shunichi, Matsumura, Hiroshi, Nakamura, Hitomi, Oshiro, Shu, Arakawa, Yasuo, Hayashi, Junpei, Sekine, Naoki, Nirei, Kazushige, Yamagami, Hiroaki, Ogawa, Masahiro, Nakajima, Noriko, Amaki, Shuichi, Tanaka, Naohide, Moriyama, Mitsuhiko
Formato: Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771250/
https://www.ncbi.nlm.nih.gov/pubmed/19902019
http://dx.doi.org/10.3164/jcbn.08-246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771250/
https://www.ncbi.nlm.nih.gov/pubmed/19902019
http://dx.doi.org/10.3164/jcbn.08-246

Ejemplares similares